MIR4776-2: A Drug Target / Disease Biomarker (G100616472)
MIR4776-2: A Drug Target / Disease Biomarker
MIR4776-2 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MIR4 family of non-coding RNA-binding proteins, which are known for their ability to interact with RNA molecules.
One of the unique features of MIR4776-2 is its ability to interact with specific types of RNA, known as microRNAs (miRNAs). MiRNAs are small non-coding RNAs that are derived from larger RNA molecules, and they play a critical role in regulating gene expression.
MIR4776-2 has been shown to play a role in the regulation of gene expression in various tissues of the body. For example, studies have shown that MIR4776-2 can interact with miRNAs that are involved in the regulation of cell proliferation, differentiation, and survival.
In addition to its role in gene regulation, MIR4776-2 has also been shown to play a role in the development and progression of various diseases. For example, studies have shown that MIR4776-2 is expressed in various tissues of the brain and that it is involved in the regulation of neural cell proliferation and differentiation.
Due to its involvement in the regulation of gene expression and disease progression, MIR4776-2 has potential as a drug target or biomarker. Researchers are currently working to develop compounds that can specifically interact with MIR4776-2 and enhance its ability to regulate gene expression and disease progression.
In conclusion, MIR4776-2 is a protein that has important roles in the regulation of gene expression and disease progression. Its potential as a drug target or biomarker makes it an attractive target for further research and development.
Protein Name: MicroRNA 4776-2
The "MIR4776-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4776-2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2
